EMG-Guided Botulinum Toxin Injection for Cervical Vertigo

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for cervical vertigo caused by neck muscle dystonia are not consistently effective, as they lack precision in targeting overactive muscles, leading to variable success rates.

Innovation Solution

EMG-guided injections of botulinum toxin into selectively identified overactive neck muscles using an EMG needle assembly with a hollow needle and syringe body, allowing for precise administration based on muscle activity levels.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional treatments (physical therapy, medications, injections) are used for cervical vertigo, then treatment coverage is broad, but treatment effectiveness is variable and success rates are inconsistent

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidtreatment customization
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent applies local quality by using EMG guidance to identify and treat specific overactive neck muscles individually rather than applying uniform treatment to the entire cervical region. Each muscle is assessed for overactivity and injected with botulinum toxin based on its specific EMG findings, creating a customized local treatment approach that improves reliability while maintaining adaptability.

Inventive Principle:
Principle #3Local quality

2Manufacturing precision

If EMG-guided botulinum toxin injections are used, then treatment precision is improved, but device complexity increases

Engineering Contradiction:
Improveinjection precisionVSAvoidEMG-guided system complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent merges the EMG diagnostic function with the injection delivery system by using the same needle for both EMG signal acquisition and botulinum toxin injection. This integration eliminates the need for separate diagnostic and treatment devices, reducing overall system complexity while maintaining high injection precision through real-time EMG guidance.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The injection needle serves multiple functions: it acts as both an EMG electrode for detecting muscle overactivity and as a delivery conduit for botulinum toxin. This multi-functionality reduces the number of separate devices needed, simplifying the overall system while enabling precise, guided injections.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Reliability

If multiple treatment modalities are applied, then treatment coverage is comprehensive, but treatment time and resource consumption increase

Engineering Contradiction:
Improvetreatment success rateVSAvoidtreatment duration
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent performs preliminary EMG assessment to identify overactive muscles before injection, allowing for targeted treatment of only the specific muscles contributing to cervical vertigo. This preliminary identification step eliminates the need for trial-and-error treatment of multiple muscle groups, reducing overall treatment time while maintaining high success rates through precise targeting.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method provides quick and effective relief from cervical vertigo by reducing muscle overactivity and spasm, consistently improving symptoms in patients with cervical dystonia by normalizing proprioceptive input.

Implementation Method 1

an EMG needle assembly that includes a hollow needle with an electrode at its tip

Methodology Applied
Scientific EffectElectrical conduction: Conduction (electrical)

Implementation Method 2

EMG-guided injections of botulinum toxin into selective dystonic neck muscles

Methodology Applied
Scientific EffectNeuromuscular blockade:

Data Source

PatentUS20240108283A1Method of Treating Cervical Vertigo
Publication Date: 2024.04.04 ODDERSON IB R
  • US20240108283A1 patent drawing

AI summary

A method of quickly and effectively treating cervical vertigo by using EMG-guided injections of botulinum toxin into selective dystonic neck muscles. For each treatment, EMG-guided injections are used wherein an EMG needle is injected into the muscle. An EMG test is then performed using the EMG needle to determine if the muscle is overactive. If the muscle is overactive, a measured amount of botulinum toxin is administered into the muscle using the EMG needle. Muscles that are not overactive are not administered botulinum toxin. The above procedure is conducted in various neck muscles, such as the oblique capitis superior muscle, the oblique capitis inferior muscle, the longissimus capitis muscle, the trapezius, and the levator scapula.